Clinical Trials – Where are we Headed with COVID-19 Trials?
Powered by
All the vital news, analysis, and commentary curated by our industry experts.
Covid 19 Clinical Trials Market Overview
The greatest number of COVID-19 clinical trials were in Phase II. Q2 2020 is still the time period that had the highest number of trials since the beginning of the COVID-19 pandemic. Clinical trials for COVID-19 vaccines have increased over time since the beginning of the pandemic. Although the total number of vaccines for COVID-19 clinical trials have increased, there were far fewer vaccine trials in Q1 2022 compared to Q1 2021.
Which are the key regions in the COVID-19 clinical trials market?
The key regions in the COVID-19 clinical trials market are Asia -Pacific, North America, Europe, Middle East & Africa, and South & Central America. Asia-Pacific has the most Phase I, Phase II, and Phase IV clinical trials, while the Middle East and Africa has the most Phase III clinical trials.
COVID-19 clinical trials market, by regions
For more regional insights, download a free report sample
Which are the key countries in the COVID-19 clinical trials market?
The key countries in the COVID-19 clinical trials market are the US, India, the UK, Brazil, and China. The US greatly outnumbered all other countries in the number of COVID-19 clinical trial sites.
COVID-19 clinical trials market, by countries
For more country insights, download a free report sample
Which are the key industry sponsors in the COVID-19 clinical trials market?
The key industry sponsors in the COVID-19 clinical trials market are Sorrento Therapeutics, Elli Lilly, Novartis, Pfizer, Hamad Medical, Gilead Sciences, Regeneron Pharmaceuticals, Atea Pharmaceuticals, and AstraZeneca. The top industry sponsor for COVID-19 therapeutic clinical trials was Sorrento Therapeutics, compared to the number of trials reported in 2021.
COVID-19 clinical trials market, by industry sponsor
To know more about industry sponsors, download a free report sample
Which are the key non-industry sponsors in the COVID-19 clinical trials market?
The key non-industry sponsors in the COVID-19 clinical trials market are Shahid Beheshti University of Medical Sciences, Tehran University of Medical Sciences, Mashhad University of Medical Sciences, Assistance Publique – Hopitaux De Paris, Tabriz University of Medical Sciences, Mazandaran University of Medical Sciences, and Isfahan University of Medical Sciences.
COVID-19 clinical trials market, by non-industry sponsor
To know more about non-industry sponsors, download a free report sample
Market report overview
Key regions | Asia-Pacific, North America, Europe, Middle East & Africa, and South & Central America |
Key countries | The US, India, the UK, Brazil, and China |
Key industry sponsors | Sorrento Therapeutics, Elli Lilly, Novartis, Pfizer, Hamad Medical, Gilead Sciences, Regeneron Pharmaceuticals, Atea Pharmaceuticals, and AstraZeneca |
Key non-industry sponsors | Shahid Beheshti University of Medical Sciences, Tehran University of Medical Sciences, Mashhad University of Medical Sciences, Assistance Publique – Hopitaux De Paris, Tabriz University of Medical Sciences, Mazandaran University of Medical Sciences, and Isfahan University of Medical Sciences |
Scope
- The clinical trials data used for these analyses were extracted from GlobalData’s Clinical Trials Database. The data included clinical trials, which were captured in the database as of March 30, 2022. The trials were analyzed and segmented by all COVID-19 trials, trials using vaccines, trials using therapeutics, and all trials impacted due to the pandemic. An analysis was also completed on COVID-19 testing and vaccination data.
Reasons to Buy
- Trends of COVID-19 trials by phase, sponsor type and status
- Geographical distribution of COVID-19 trials
- Comparison of COVID-19 trials by vaccines versus therapeutics
- Impact of COVID-19 of clinical trials
- COVID-19 testing and vaccination data
Table of Contents
Table
Figures
Frequently asked questions
-
Which are the key regions in the COVID-19 clinical trials market?
The key regions in the COVID-19 clinical trials market are Asia -Pacific, North America, Europe, Middle East & Africa, and South & Central America.
-
Which are the key countries in the COVID-19 clinical trials market?
The key countries in the COVID-19 clinical trials market are the US, India, the UK, Brazil, and China.
-
Which are the key industry sponsors in the COVID-19 clinical trials market?
The key industry sponsors in the COVID-19 clinical trials market are Sorrento Therapeutics, Elli Lilly, Novartis, Pfizer, Hamad Medical, Gilead Sciences, Regeneron Pharmaceuticals, Atea Pharmaceuticals, and AstraZeneca.
-
Which are the key non-industry sponsors in the COVID-19 clinical trials market?
The key non-industry sponsors in the COVID-19 clinical trials market are Shahid Beheshti University of Medical Sciences, Tehran University of Medical Sciences, Mashhad University of Medical Sciences, Assistance Publique – Hopitaux De Paris, Tabriz University of Medical Sciences, Mazandaran University of Medical Sciences, and Isfahan University of Medical Sciences.
Get in touch to find out about multi-purchase discounts
reportstore@globaldata.com
Tel +44 20 7947 2745
Every customer’s requirement is unique. With over 220,000 construction projects tracked, we can create a tailored dataset for you based on the types of projects you are looking for. Please get in touch with your specific requirements and we can send you a quote.
Related reports
View more Pharmaceuticals reports![](https://www.globaldata.com/store/wp-content/uploads/sites/2/blue_1bg2.webp)